FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Extends Review Timeline for Aldeyras Dry Eye Drug

FDA extends the review of Aldeyra Therapeutics NDA resubmission for reproxalap, pushing back a regulatory decision on the investigational dry eye dise...

latest-news-card-1

Guide to Increase Female Enrollment in Trials

FDA publishes a draft guidance aimed at increasing the enrollment of females in clinical trials of drugs and medical devices.

latest-news-card-1
Human Drugs

Trump Taps Controversial Figure to Lead Cancer Panel

President Trump appoints Yale epidemiologist Harvey Risch to chair the Presidents Cancer Panel, a move that is raising alarm among cancer researchers ...

latest-news-card-1
Human Drugs

7 Observations on ProRx FDA-483

FDA releases the form FDA-483 with seven observations from an inspection at the Exton, PA-based ProRx outsourcing facility.

latest-news-card-1
Human Drugs

Sanofi Scraps Tolebrutinib MS Filing after Phase 3 Miss

Sanofi says it will not seek FDA approval for tolebrutinib in primary progressive multiple sclerosis after the drug failed to meet its primary endpoin...

latest-news-card-1
FDA General

Restrictions on Real-World Evidence Regulatory Reviews Eased

FDA says it is removing a long-standing barrier to the use of real-world evidence in regulatory reviews by accepting such data without requiring ident...

latest-news-card-1
FDA General

2 Guides Posted on Product Safety Reporting

FDA posts two final guidances that provide recommendations to help clinical investigators comply with the safety reporting requirements for IND and ID...

latest-news-card-1
Medical Devices

GAO Flags Staffing Gaps and Legal Limits With Device Recalls

The Government Accountability Office urges HHS to shore up staffing and reassess legal authorities at FDA after finding significant weaknesses in how ...

latest-news-card-1
Human Drugs

FDA OKs Enhertu Combo as First-Line for Advanced Breast Cancer

FDA approves Daiichi Sankyos Enhertu (fam-trastuzumab deruxtecan-nxki) in combination with Genentechs pertuzumab as a first-line treatment for adults ...

latest-news-card-1
Human Drugs

FDA Urges Broader, More Inclusive Clinical Trials

FDA posts updated guidance calling on drug and biologics developers to broaden eligibility criteria, modernize enrollment practices, and adopt more fl...